Evidence map›Paper›PMID 33037284›Full record

ArticleScientific reports2020

Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study.

Maryna V Basalay, Marlene Wiart, Fabien Chauveau, Chloe Dumot, Christelle Leon, Camille Amaz, Radu Bolbos, Diana Cash, Eugene Kim, Laura Mechtouff and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Mitochondria dysfunction, a potential cytoprotection target against ischemia-reperfusion injury in a mouse stroke model.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Remote Ischemic Conditioning and Stroke Recovery.Neurorehabilitation and neural repair · 2021
    Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Maryna V Basalay *The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.
Marlene Wiart *Univ Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.
Fabien ChauveauUniv Lyon, Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, Université Claude Bernard Lyon 1, Lyon, France.
Chloe DumotUniv Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.
Christelle LeonUniv Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.
Camille AmazClinical Investigation Center, CIC 1407, HCL, Louis Pradel Hospital, Lyon, France.
Radu BolbosCERMEP-Imagerie du Vivant, Lyon, France.
Diana CashDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Eugene KimDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Laura MechtouffUniv Lyon, CREATIS, CNRS UMR 5220, INSERM U1206, INSA-Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Tae-Hee ChoUniv Lyon, CREATIS, CNRS UMR 5220, INSERM U1206, INSA-Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Norbert NighoghossianUniv Lyon, CREATIS, CNRS UMR 5220, INSERM U1206, INSA-Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Sean M DavidsonThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.
Michel OvizeUniv Lyon, CarMeN Laboratory, INSERM 1060, INRA U1397, INSA Lyon, Université Claude Bernard Lyon 1, Oullins, France.
Derek M YellonThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac.uk.ORCID http://orcid.org/0000-0001-7791-9320
Université Claude Bernard Lyon 1 · FRUniversity College London · GBKing's College London · GBCentre d'Exploration et de Recherche Médicale par Emission de Positons · FRHospices Civils de Lyon · FR

Funding

Department of Health BRC233/CM/SD/101320
6 · The paper itself

Abstract

Reperfusion is the only existing strategy for patients with acute ischemic stroke, however it causes further brain damage itself. A feasible therapy targeting reperfusion injury is remote ischemic conditioning (RIC). This was a two-centre, randomized, blinded international study, using translational imaging endpoints, aimed to examine the neuroprotective effects of RIC in ischemic stroke model. 80 male rats underwent 90-min middle cerebral artery occlusion. RIC consisted of 4 × 5 min cycles of left hind limb ischemia. The primary endpoint was infarct size measured on T2-weighted MRI at 24 h, expressed as percentage of the area-at-risk. Secondary endpoints were: hemispheric space-modifying edema, infarct growth between per-occlusion and 24 h MRI, neurofunctional outcome measured by neuroscores. 47 rats were included in the analysis after applying pre-defined inclusion criteria. RIC significantly reduced infarct size (median, interquartile range: 19% [8%; 32%] vs control: 40% [17%; 59%], p = 0.028). This effect was still significant after adjustment for apparent diffusion coefficient lesion size in multivariate analysis. RIC also improved neuroscores (6 [3; 8] vs control: 9 [7; 11], p = 0.032). Other secondary endpoints were not statistically different between groups. We conclude that RIC in the setting of acute ischemic stroke in rats is safe, reduces infarct size and improves functional recovery.

Indexed as

NeuroprotectionAnimalsDisease Models, AnimalIschemic PostconditioningIschemic PreconditioningIschemic StrokeMaleRats, Sprague-DawleyRecovery of FunctionSafetyTreatment Outcome

Identifiers

PMID33037284
PMCPMC7547701
OpenAlexW3092150873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.